FR2346007A1 - Nouvelles compositions anti-inflammatoires administrables per os - Google Patents

Nouvelles compositions anti-inflammatoires administrables per os

Info

Publication number
FR2346007A1
FR2346007A1 FR7609044A FR7609044A FR2346007A1 FR 2346007 A1 FR2346007 A1 FR 2346007A1 FR 7609044 A FR7609044 A FR 7609044A FR 7609044 A FR7609044 A FR 7609044A FR 2346007 A1 FR2346007 A1 FR 2346007A1
Authority
FR
France
Prior art keywords
resistant coating
proteolytic enzymes
oxyphenbutazone
gastro
butazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7609044A
Other languages
English (en)
Other versions
FR2346007B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CREAT
Original Assignee
CREAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CREAT filed Critical CREAT
Priority to FR7609044A priority Critical patent/FR2346007A1/fr
Publication of FR2346007A1 publication Critical patent/FR2346007A1/fr
Application granted granted Critical
Publication of FR2346007B1 publication Critical patent/FR2346007B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7609044A 1976-03-29 1976-03-29 Nouvelles compositions anti-inflammatoires administrables per os Granted FR2346007A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7609044A FR2346007A1 (fr) 1976-03-29 1976-03-29 Nouvelles compositions anti-inflammatoires administrables per os

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7609044A FR2346007A1 (fr) 1976-03-29 1976-03-29 Nouvelles compositions anti-inflammatoires administrables per os

Publications (2)

Publication Number Publication Date
FR2346007A1 true FR2346007A1 (fr) 1977-10-28
FR2346007B1 FR2346007B1 (fr) 1979-05-18

Family

ID=9171071

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7609044A Granted FR2346007A1 (fr) 1976-03-29 1976-03-29 Nouvelles compositions anti-inflammatoires administrables per os

Country Status (1)

Country Link
FR (1) FR2346007A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135022A2 (fr) * 1983-07-27 1985-03-27 Beecham Group Plc Composition contenant un allergène
EP0196002A2 (fr) * 1985-03-25 1986-10-01 Abbott Laboratories Comprimés contenant une combinaison de médicaments

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135022A2 (fr) * 1983-07-27 1985-03-27 Beecham Group Plc Composition contenant un allergène
EP0135022A3 (fr) * 1983-07-27 1986-11-26 Beecham Group Plc Composition contenant un allergène
EP0196002A2 (fr) * 1985-03-25 1986-10-01 Abbott Laboratories Comprimés contenant une combinaison de médicaments
EP0196002A3 (en) * 1985-03-25 1987-12-02 Abbott Laboratories Tablet composition for drug combinations

Also Published As

Publication number Publication date
FR2346007B1 (fr) 1979-05-18

Similar Documents

Publication Publication Date Title
AU646399B2 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
AU6541786A (en) Process for producing an administration or dosage form of drugs, reagents or other active ingredients
NO883667D0 (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
AU2363588A (en) Plurality of tiny pills in liquid dosage form
CA2145513A1 (fr) Comprime pouvant liberer a differentes vitesses un ou plusieurs medicaments
HUT69397A (en) Process for producing retard composition with diffusive-osmotic release
EP0259219A3 (fr) Comprimé à libération commandée
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
EP0339811A3 (en) Aqueous based pharmaceutical coating composition for dosage forms
EP1123087A4 (fr) Systeme d'administration de medicaments par doses pulsees par voie orale
EP0235718A3 (en) Granule remaining in stomach
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
IE883810L (en) Sustained release pharmaceutical compositions
ID28275A (id) Penghantaran kolon dan enterik yang menggunakan kapsul-kapsul hpmc
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
IE821214L (en) Medicament
MY103455A (en) Chewable medicament tablet containing means for taste masking
EP0282011A3 (fr) Formulation pharmaceutique à libération contrôlée et prolongée
CA2063141A1 (fr) Rotogranulations et enrobages sapides pour des preparations de comprimes pharmaceutiques croquables
EP0616802A4 (fr) Preparation administree par voie orale et destinee a etre liberee dans le tube digestif inferieur.
FR2346007A1 (fr) Nouvelles compositions anti-inflammatoires administrables per os
CA2079934A1 (fr) Enrobages permettant de masquer le gout de comprimes pharmaceutiques machables
CA2052679A1 (fr) Rotogranulations et enrobages masquant les saveurs dans la preparation de comprimes pharmaceutiques a croquer
AU7415181A (en) Polymeric diffusion matrix for administration of drugs
EP0302714A3 (fr) Composition pharmaceutique pour le traitement des maladies affaiblissant les os

Legal Events

Date Code Title Description
TP Transmission of property
CA Change of address
CD Change of name or company name
TP Transmission of property
TP Transmission of property
ST Notification of lapse